Clinical trial
Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder: A Randomized Controlled Trial (NOVASTIM)
NCT07780786 is registered in ClinicalTrials.gov with NinaMED Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder: A Randomized Controlled Trial (NOVASTIM)
- Lead sponsor
- NinaMED Pty Ltd
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 10, 2026
- Completion date
- January 30, 2028
- Enrollment
- 290 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder (oab)